IGF1 receptor inhibition amplifies the effects of cancer drugs by autophagy and immune-dependent mechanisms
Background Pharmacological autophagy enhancement constitutes a preclinically validated strategy for preventing or treating most major age-associated diseases. Driven by this consideration, we performed a high-content/high-throughput screen on 65 000 distinct compounds on a robotized fluorescence mic...
Saved in:
| Main Authors: | Qi Wu, Shuai Zhang, Peng Liu, Wei Xie, Guido Kroemer, Oliver Kepp, Bei Li, Pan Hui, Ai-Ling Tian, Marion Leduc, Sabrina Forveille, Peter Hamley, Warren Galloway, Liwei Zhao, Frank Madeo, Yi Tu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2021-06-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/9/6/e002722.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Datopotamab deruxtecan induces hallmarks of immunogenic cell death
by: Sabrina Forveille, et al.
Published: (2025-08-01) -
Patritumab deruxtecan induces immunogenic cell death
by: Sabrina Forveille, et al.
Published: (2025-12-01) -
How macrophages use extracellular calreticulin to chase their prey
by: Liwei Zhao, et al.
Published: (2025-12-01) -
PD-L1+ macrophages suppress T cell-mediated anticancer immunity
by: Peng Liu, et al.
Published: (2024-12-01) -
Cytoplasmic HMGB2 orchestrates CALR translocation in the course of immunogenic cell death
by: Peng Liu, et al.
Published: (2024-12-01)